News & Updates

Use of nonsteroidal anti-inflammatory drugs (NSAIDs) tends to elevate the risk of first-time hospitalization for heart failure (HF) in patients with type 2 diabetes mellitus (T2DM), a study has shown. In addition, those with advanced age, elevated haemoglobin (Hb) A1c levels, and new users are particularly at higher risk.

The angiotensin receptor neprilysin inhibitor sacubitril/valsartan, used for heart failure, appears to have potent effects on 24‐hour blood pressure (BP) in Japanese patients with mild‐to‐moderate hypertension and in the subgroup of those with nondipping BP pattern, as shown in a study.

Eating at least 1.5 servings of fish each week does not appear to improve cardiovascular (CV) outcomes, reports a recent study, noting that its potential benefit must not be ruled out completely.

A significant association exists between fasting plasma glucose (FPG) trajectories and the lifetime risk of cardiovascular disease (CVD), reveals a study.

For patients with obesity and type 2 diabetes mellitus (T2DM) who are scheduled to undergo metabolic surgery, the presence of hypertension and hypercholesterolemia at baseline may predict failure of T2DM remission after the procedure, according to a study.

Initial frailty status appears to be a potential predictor of the occurrence of the composite of probable dementia and mild cognitive impairment, and this association is strengthened by intensive blood pressure control, as reported in a study.

Subclinical, obstructive coronary atherosclerosis contributes to a more than eightfold increase in the risk for myocardial infarction among asymptomatic individuals, a study has shown.